TSE:7733Medical Equipment
How Olympus’ EAGLE Trial AI Endoscopy Results Could Impact Olympus (TSE:7733) Investors
Olympus Corporation recently announced positive multicenter EAGLE Trial results for its FDA-cleared and CE-marked CADDIE AI device, showing improved real-time polyp and adenoma detection during colonoscopy without disrupting safety or workflow.
The trial underscores Olympus’s push to embed cloud-based AI into its OLYSENSE Intelligent Endoscopy Ecosystem, potentially strengthening the clinical appeal of its endoscopy platform for hospitals and gastroenterologists.
We’ll now examine how the...